Eurofins Scientific SE
ERFSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $6,951 | $6,515 | $6,712 | $6,718 |
| % Growth | 6.7% | -2.9% | -0.1% | – |
| Cost of Goods Sold | $2,239 | $5,140 | $2,227 | $2,150 |
| Gross Profit | $4,712 | $1,375 | $4,485 | $4,568 |
| % Margin | 67.8% | 21.1% | 66.8% | 68% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $136 | $39 | $60 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $3,986 | $0 | $3,663 | $3,238 |
| Operating Expenses | $3,986 | $136 | $3,702 | $3,298 |
| Operating Income | $726 | $1,239 | $1,385 | $1,261 |
| % Margin | 10.4% | 19% | 20.6% | 18.8% |
| Other Income/Exp. Net | -$172 | -$816 | -$605 | -$204 |
| Pre-Tax Income | $555 | $423 | $780 | $1,057 |
| Tax Expense | $149 | $116 | $174 | $274 |
| Net Income | $406 | $310 | $610 | $783 |
| % Margin | 5.8% | 4.8% | 9.1% | 11.6% |
| EPS | 2.13 | 1.07 | 3.17 | 4.09 |
| % Growth | 99.1% | -66.2% | -22.5% | – |
| EPS Diluted | 2.09 | 1.3 | 3.07 | 3.9 |
| Weighted Avg Shares Out | 191 | 239 | 193 | 192 |
| Weighted Avg Shares Out Dil | 195 | 198 | 199 | 201 |
| Supplemental Information | – | – | – | – |
| Interest Income | $19 | $12 | $2 | $2 |
| Interest Expense | $151 | $129 | $106 | $95 |
| Depreciation & Amortization | $469 | $664 | $444 | $390 |
| EBITDA | $1,367 | $1,217 | $1,353 | $1,542 |
| % Margin | 19.7% | 18.7% | 20.2% | 22.9% |